Alexander Mark Schobel, Chief Innovation/Tech Officer at Aquestive Therapeutics, Inc. (AQST), sold 80,000 shares at $4.00 ($308K) on 2020-04-27, disclosed to the SEC on 2020-05-04.
Open-market sale of $308k AQST by Chief Innovation/Tech Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.70 | 40,000 | $148K | 48.1% |
| 2 | $4.00 | 40,000 | $160K | 51.9% |
| Total | $3.85 avg | 80,000 | $308K | 100% |
| Filing → |
| AQST | BUY | 2022-06-10 | $44K | — | Filing → |
| AQST | SELL | 2021-02-10 | $236K | — | Filing → |
| AQST | SELL | 2021-02-09 | $265K | — | Filing → |